Cholesterol Testing Services Market Trends

The rising prevalence of cardiovascular diseases is a significant driver for cholesterol testing services industry. Risk factors for cardiovascular disease (CVD), including pulmonary arterial hypertension, hypercholesterolemia, diabetes, and smoking, are becoming increasingly prevalent worldwide.  

• According to the American Heart Association, in 2023, the prevalence of CVD was 607.64 million cases in 2020, an increase of 29.01% compared with 2010. Further, as per the Centers for Disease Control and Prevention, in 2023, coronary heart disease is the most common type of heart disease that killed 375,476 people in 2022.
  
• Similarly, as per the American Heart Association (AHA) report, in 2023, valvular heart disease affects about 2.5% of the U.S. population. Further, the prevalence is much higher in older adults, with around 13% of people born before 1943 having valvular heart disease.
  
• Further, according to the World Health Organization (WHO), in 2023, cardiovascular diseases (CVDs) are the leading cause of death globally, taking an estimated 17.9 million lives each year.
  
• Early detection of risk factors such as dyslipidemia (abnormal cholesterol levels) is crucial for preventing the development and progression of CVD. Cholesterol testing helps identify individuals at risk of cardiovascular events, enabling healthcare providers to initiate preventive measures such as lifestyle modifications, medication therapy, and cardiovascular risk reduction strategies.